Synageva BioPharma (GEVA) Misses Q1 EPS by 2c
Tweet
Share
E-mailGet Alerts GEVA Hot Sheet
Join SI Premium – FREE
Synageva BioPharma (NASDAQ: GEVA) reported Q1 EPS of ($1.73), $0.02 worse than the analyst estimate of ($1.71).
For earnings history and earnings-related data on Synageva BioPharma (GEVA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meritage Homes Corporation (MTH) Tops Q1 EPS by 151c; offers guidance
- Universal Health Realty (UHT) Reports Q1 EPS of $0.38
- First Bancshares (FBMS) Tops Q1 EPS by 6c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
